Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer

被引:18
|
作者
McDow, Alexandria D. [1 ]
Roman, Benjamin R. [2 ]
Saucke, Megan C. [3 ]
Jensen, Catherine B. [3 ]
Zaborek, Nick [4 ]
Jennings, Jamia Linn [5 ]
Davies, Louise [6 ,7 ]
Brito, Juan P. [8 ]
Pitt, Susan C. [3 ]
机构
[1] Indiana Univ Sch Med, Dept Surg, Div Surg Oncol, 545 Barnhill Dr EH 537, Indianapolis, IN 46202 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Head & Neck, 1275 York Ave, New York, NY 10065 USA
[3] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, 600 Highland Ave, Madison, WI 53792 USA
[4] Univ Wisconsin, Dept Biostat & Med Informat, Sch Med & Publ Hlth, 600 Highland Ave, Madison, WI 53792 USA
[5] Wisconsin Dept Hlth Serv, 1 West Wilson St, Madison, WI 53703 USA
[6] Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT USA
[7] Dartmouth Inst Hlth Policy & Clin Practice, 1 Med Ctr Dr, Lebanon, NH 03756 USA
[8] Mayo Clin, Div Diabet Endocrinol Metab & Nutr, Dept Med, 200 First St SW, Rochester, MN 55905 USA
来源
AMERICAN JOURNAL OF SURGERY | 2021年 / 222卷 / 01期
基金
美国国家卫生研究院;
关键词
Thyroid cancer; Overtreatment; Low-risk; Active surveillance; Survey; Thyroidectomy; DECISION-MAKING; PROSTATE-CANCER; PATIENT PREFERENCES; ACTIVE SURVEILLANCE; TREATMENT CHOICE; PERCEPTIONS; MANAGEMENT; MICROCARCINOMA; ONCOLOGISTS; UNCERTAINTY;
D O I
10.1016/j.amjsurg.2020.11.021
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The 2015 American Thyroid Association endorsed less aggressive management for low-risk papillary thyroid cancer (LR-PTC). We aimed to identify factors influencing physicians' recommendations for LR-PTC. Methods: We surveyed members of three professional societies and assessed respondents' recommendations for managing LR-PTC using patient scenarios. Multivariable logistic regression models identified clinical and non-clinical factors associated with recommending total thyroidectomy (TT) and active surveillance (AS). Results: The 345 respondents included 246 surgeons and 99 endocrinologists. Physicians' preference for their own management if diagnosed with LR-PTC had the strongest association with their recommendation for TT and AS (TT: OR 12.3; AS: OR 7.5, p < 0.001). Physician specialty and stated patient preference were also significantly associated with their recommendations for both management options. Respondents who received information about AS had increased odds of recommending AS. Conclusions: Physicians' recommendations for LR-PTC are strongly influenced by non-clinical factors, such as personal treatment preference and specialty. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:111 / 118
页数:8
相关论文
共 50 条
  • [1] Management of Low-Risk Papillary Thyroid Cancer
    Iniguez-Ariza, Nicole M.
    Brito, Juan P.
    [J]. ENDOCRINOLOGY AND METABOLISM, 2018, 33 (02) : 185 - 194
  • [2] Is multifocality a risk factor in low-risk papillary thyroid cancer?
    Sapuppo, Giulia
    Grasso, Sonia
    Di Benedetto, Guenda
    Marturano, Ilenia
    Costanzo, Gabriele
    Belfiore, Antonino
    Pellegriti, Gabriella
    [J]. ENDOKRYNOLOGIA POLSKA, 2022, 73 (06) : 928 - 934
  • [3] Percutaneous ablation of low-risk papillary thyroid cancer
    Tuttle, R. Michael
    Li, Duan
    Ridouani, Fourat
    [J]. ENDOCRINE-RELATED CANCER, 2023, 30 (03)
  • [4] Low-risk papillary thyroid cancer: times are changing
    Sitges-Serra, Antonio
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2014, 9 (01) : 9 - 18
  • [5] Controversies in primary treatment of low-risk papillary thyroid cancer
    McLeod, Donald S. A.
    Sawka, Anna M.
    Cooper, David S.
    [J]. LANCET, 2013, 381 (9871): : 1046 - 1057
  • [6] Is total thyroidectomy the procedure of choice for low-risk papillary thyroid cancer?
    Ruan, Daniel T.
    Clark, Orlo H.
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (03): : 128 - 129
  • [7] Is total thyroidectomy the procedure of choice for low-risk papillary thyroid cancer?
    Daniel T Ruan
    Orlo H Clark
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 : 128 - 129
  • [8] A Quantitative Analysis Examining Patients' Choice of Active Surveillance or Surgery for Managing Low-Risk Papillary Thyroid Cancer
    Sawka, Anna M.
    Ghai, Sangeet
    Rotstein, Lorne
    Irish, Jonathan C.
    Pasternak, Jesse D.
    Gullane, Patrick J.
    Monteiro, Eric
    Gooden, Everton
    Brown, Dale H.
    Eskander, Antoine
    Zahedi, Afshan
    Chung, Janet
    Su, Jie
    Xu, Wei
    Ihekire, Ogemdi
    Jones, Jennifer M.
    Gafni, Amiram
    Baxter, Nancy N.
    Goldstein, David P.
    [J]. THYROID, 2022, 32 (03) : 255 - 262
  • [9] The overuse of radioactive iodine in low-risk papillary thyroid cancer patients
    Moten, Ambria S.
    Zhao, Huaqing
    Willis, Alliric, I
    [J]. SURGICAL ONCOLOGY-OXFORD, 2019, 29 : 184 - 189
  • [10] Clinicopathological relevance of antithyroglobulin antibodies in low-risk papillary thyroid cancer
    Morand, G. B.
    da Silva, S. D.
    Mlynarek, A. M.
    Black, M. J.
    Payne, R. J.
    Hier, M. P.
    [J]. CLINICAL OTOLARYNGOLOGY, 2017, 42 (06) : 1130 - 1134